Dr. Cl?ona Murphy:

There are different approaches in different countries. For example, in Germany I do not believe there was or is a pause. Mesh itself was not taken off the market in any place. In the Netherlands, the response was along the lines of clinical governance and tightening regulations and guidelines. In New Zealand and Australia there were slightly tighter controls as well in that area. It is fair to say that mesh is being used in many other countries.